Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Application of HepG2/C3A liver spheroids as a model system for genotoxicity studies. | Toxicol Lett | 2021 | 33865918 | PubTator, text mining | PubMed |
| Identification of genes and pathways involved in malignant pleural mesothelioma using bioinformatics methods. | BMC Med Genomics | 2021 | 33849532 | PubTator, text mining | PubMed |
| CDC2-like (CLK) protein kinase inhibition as a novel targeted therapeutic strategy in prostate cancer. | Sci Rep | 2021 | 33846420 | PubTator, text mining | PubMed |
| Red meat consumption, cooking mutagens, NAT1/2 genotypes and pancreatic cancer risk in two ethnically diverse prospective cohorts. | Int J Cancer | 2021 | 33844845 | PubTator, text mining | PubMed |
| How Malaria Parasites Acquire Nutrients From Their Host. | Front Cell Dev Biol | 2021 | 33842474 | PubTator, text mining | PubMed |
| Biobank Scale Pharmacogenomics Informs the Genetic Underpinnings of Simvastatin Use. | Clin Pharmacol Ther | 2021 | 33837531 | PubTator, text mining | PubMed |
| Identification of Metabolic-Associated Genes for the Prediction of Colon and Rectal Adenocarcinoma. | Onco Targets Ther | 2021 | 33833525 | PubTator, text mining | PubMed |
| Prodrugs and prodrug-activated systems in gene therapy. | Mol Ther | 2021 | 33831557 | PubTator, text mining | PubMed |
| Functional variability of rhesus macaque (Macaca mulatta) NAT2 gene for drug-metabolising arylamine N-acetyltransferase 2. | Biochem Pharmacol | 2021 | 33831395 | PubTator, text mining | PubMed |
| Influence of N-acetyltransferase 2 gene polymorphisms on the in vitro metabolism of the epidermal growth factor receptor inhibitor rociletinib. | Br J Clin Pharmacol | 2021 | 33818816 | PubTator, text mining | PubMed |
| Functional Characterization of the Effects of N-acetyltransferase 2 Alleles on N-acetylation of Eight Drugs and Worldwide Distribution of Substrate-Specific Diversity. | Front Genet | 2021 | 33815485 | PubTator, text mining | PubMed |
| Alteration of the risk of pre-oral cancer and cancer in North Indian population by NAT1 and NAT2 polymorphisms genotypes and haplotypes. | Eur Arch Otorhinolaryngol | 2021 | 33813602 | PubTator, text mining | PubMed |
| Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice. | Antioxidants (Basel) | 2021 | 33807700 | PubTator, text mining | PubMed |
| Strategies to Improve the Clinical Outcomes for Direct-to-Consumer Pharmacogenomic Tests. | Genes (Basel) | 2021 | 33802585 | PubTator, text mining | PubMed |
| Transcriptome Analysis Identifies Novel Mechanisms Associated with the Antitumor Effect of Chitosan-Stabilized Selenium Nanoparticles. | Pharmaceutics | 2021 | 33800318 | PubTator, text mining | PubMed |
| Establishing the value of genomics in medicine: the IGNITE Pragmatic Trials Network. | Genet Med | 2021 | 33782552 | PubTator, text mining | PubMed |
| Association Between NAT2 Polymorphism and Lung Cancer Risk: A Systematic Review and Meta-Analysis. | Front Oncol | 2021 | 33777732 | PubTator, text mining | PubMed |
| MicroRNA-217 inhibits the proliferation and invasion, and promotes apoptosis of non-small cell lung cancer cells by targeting sirtuin 1. | Oncol Lett | 2021 | 33777209 | PubTator, text mining | PubMed |
| Dihydromyricetin Acts as a Potential Redox Balance Mediator in Cancer Chemoprevention. | Mediators Inflamm | 2021 | 33776577 | PubTator, text mining | PubMed |
| Construction and validation of a metabolic risk model predicting prognosis of colon cancer. | Sci Rep | 2021 | 33767290 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=35